On ECHEMI
Home > Drugs > Dihydroergotamine mesylate Registered Holders
Dihydroergotamine mesylate structure

Dihydroergotamine mesylate structure

Dihydroergotamine mesylate

Dihydroergotamine mesylate is an ergot alkaloid used to treat migraines.Target: 5-HT ReceptorsDihydroergotamine is not as effective as sumatriptan or phenothiazines as a single agent for treatment of acute migraine headache; however, when administered with an antiemetic, dihydroergotamine appears to be as effective as opiates, ketorolac, or valproate. Given its nonnarcotic properties, parenteral dihydroergotamine combined with an antiemetic should be considered as effective initial thera

Find 7 Related Holders

OLON S.P.A.
Italy Italy

API Registration Country

API Active
  • Country:

    Italy Italy
  • Address:

    (MI) STRADA RIVOLTANA KM 6/7
  • Email:

TAPI NL B.V.
France France

API Registration Country

API Active
  • Founded in:

    2025-02-04 00:00:00
  • Country:

    France France
  • Address:

    55 Piet Heinkade 1019GM Amsterdam PAYS-BAS
  • Email:

CURIA ITALY S.R.L.
European Union European Union

API Registration Country

API Active
TAPI CZECH INDUSTRIES S.R.O.
European Union European Union

API Registration Country

API Active
BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG
United States United States

API Registration Country

API Inactive
LEK PHARMACEUTICALS DD
United States United States

API Registration Country

API Inactive
Boehringer Ingelheim Pharma GmbH & Co. KG
European Union European Union

API Registration Country

API Inactive
Recommended Suppliers of Dihydroergotamine mesylate
Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.